Drug law enforcement efforts receive ample funding each year while drug treatment options remain shamefully underfunded. Many people who seek help for their problematic drug use are unable to access treatment, encountering insurance barriers, months-long wait lists, or programs that don't meet their needs. Far too many people are only able to access drug treatment as a result of an arrest or criminal conviction.
DPA advocates expanding drug treatment access to meet need, as well as broadening the definition of drug treatment to include models of care that incorporate harm reduction principles and prioritize health, safety, and improving quality of life over strict abstinence.
We are changing the national dialogue around treatment by raising awareness about proven drug treatment models, like heroin assisted treatment, that have been researched and employed successfully abroad but are still not available in the United States. Through these efforts, we are laying the foundation for more diverse and effective drug treatment options.
One Bill Creates a Safe and Supervised Space for People to Use Drugs; The Other Would Establish a Pilot Program to Treat Opioid Dependence with Poly-Morphone Therapy
Proposals are Part of Groundbreaking Package of Harm Reduction Drug Policy Bills That Would Also Decriminalize Small Amounts of All Drugs and Provide Treatment-at-Need in ER’s and Hospitals
Tuesday at 1pm, the Maryland House of Delegates will hold legislative hearings on two progressive legislative proposals aimed at treating drug use as a health issue. House Bill 1212 permits the establishment of safe consumption programs, which allow individuals to consume controlled substances in a safe space, provide sterile equipment, and connect patients to treatment, medical care, and other social services.
Gov. Shumlin Declares Drug War a Failure and Calls for Expanded Overdose Prevention and Treatment Access
Vermont Governor Peter Shumlin called on lawmakers to pass legislation legalizing and regulating marijuana in his final State of the State address today. He also declared the drug war a failure and expressed desire to continue emphasizing a health-based approach to drug policy by expanding treatment and overdose prevention programs, as well as by removing the stigma associated with drug use and addiction.
Springfield, IL- In a vote of 105-5, the Illinois House of Representatives voted to override Governor Rauner’s amendatory veto of HB1, the Heroin Crisis Bill, which was filed in response to the growing problem of opioid overdose and addiction in Illinois. The bill had previously passed unanimously in the Illinois House and nearly unanimously in the Illinois Senate.
Harm reduction services and syringe exchange are more than just a prevention strategy. Access to these vital services enables HIV testing, linkage to care and other critical health/social services, as well as affirming the human rights and dignity of people who use drugs.
Advocates: Public Health Goals Are Positive, But Overreliance on Law Enforcement Destined to Fail
Obama Administration Urged to Take More Meaningful Steps to Treat Drug Use as a Health Issue
Washington, D.C. – The Obama Administration announced a new program today to fund “public health-public safety partnerships” to address the heroin and prescription opioid crisis. The new program would hire 15 drug intelligence officers and 15 health policy analysts to work within High Intensity Drug Trafficking Area (HIDTA) programs. The drug intelligence officers are expected to gather information on trafficking patterns and trends for street-level law enforcement.
Advocates Urge the Governor to Sign the Bill and Embrace Evidence-based, Public Health Approaches to Addressing Opioid Use and Overdose
Albany — Yesterday, the New York State Senate passed legislation supporting the use of medication assisted treatment in drug courts. The bill -- S.4239-B (Murphy) /A.6255-B (Rosenthal) -- passed the Assembly with overwhelming support last month.
On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development Committee. Nadelmann also submitted complementary written testimony. SB275 would create a four-year heroin-assisted treatment pilot program—the first in the United States. Heroin-assisted treatment is a feasible, effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs have failed.
International Experts to Testify on Incontrovertible Scientific Evidence Demonstrating Heroin-assisted Treatment is a Feasible, Proven, and Cost-Effective Intervention
Today, the Nevada State Senate will hold the first-ever legislative hearing on heroin-assisted treatment. Senate Bill 275, which would establish a four-year pilot program, will be heard in the Revenue and Economic Development Committee at 3:30 p.m. today.
Heroin-assisted treatment, also known as heroin maintenance, is an effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs, like residential rehabilitation or methadone, have failed.
Senate Bill 275 Would Create a Four-year Pilot Program
Heroin-assisted Treatment Programs Have Proven Successful in Reducing Overdoses, Disease and Crime in Numerous Countries, Including Germany, UK, Spain, Canada and more
Last week, Nevada State Senator Richard Segerblom introduced groundbreaking legislation, Senate Bill 275, which creates a four-year heroin-assisted treatment pilot project.
Heroin-assisted treatment, also known as heroin maintenance, refers to the supervised administration by a doctor of pharmaceutical-grade heroin (diacetylmorphine) to a small group of chronic heroin users who have failed more traditional forms of treatment including abstinence-based models and medication such as methadone.